Peptigroupe Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg (NCT04428684) | Peptigroupe Inc. | 2018-10-29 |
Track Peptigroupe Inc. automatically
Every clearance here is in the API, with alerts when new ones post.